Clinical trial

Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic Neoplasms

NCT00666926

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention PF00562271 Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic Neoplasms

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-12-01

PhasePHASE1

Conditions

Head and Neck Neoplasmverified · MONDO: head and neck neoplasm

Prostatic Neoplasmunresolved

Pancreatic Neoplasmverified · MONDO: pancreatic neoplasm

Interventions

PF00562271DRUG

Sponsors & collaborators

Verastem, Inc.lead sponsor

Mapped research locations

TorontoOntario, Canada1 NashvilleTennessee, United States1 AuroraColorado, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00666926 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.